Xin Zeng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis (NCT05863364) | Xin Zeng | 2023-08-18 |
Track Xin Zeng automatically
Every clearance here is in the API, with alerts when new ones post.